AR012341A1 - Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos - Google Patents
Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentosInfo
- Publication number
- AR012341A1 AR012341A1 ARP980101559A ARP980101559A AR012341A1 AR 012341 A1 AR012341 A1 AR 012341A1 AR P980101559 A ARP980101559 A AR P980101559A AR P980101559 A ARP980101559 A AR P980101559A AR 012341 A1 AR012341 A1 AR 012341A1
- Authority
- AR
- Argentina
- Prior art keywords
- estra
- dien
- manufacture
- pharmaceutical composition
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J21/005—Ketals
- C07J21/008—Ketals at position 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J17/005—Glycosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos derivados de estradienos que comprenden el estra-5(10),7-dien-3 Beta-ol-17ona o una sal farmacéuticamente aceptable de su éster de 3-sulfato,3-glucuronido de estra-5(10),7-dien-3beta-ol-17-ona o una sal farmacéuticamente aceptable delmis mo, estra-5(10),7-dien-3alfa-ol-17-ona o una salfarmacéuticamente aceptable de su éster de 3-sulfato, y, 3-glucuronido de estra-5(10),7-dien-3alfa-ol-17-ona o una sal farmacéuticamente aceptable delmismo, así como la sal de metal3-alcalino de estra-5(10),7-dien-3beta-ol-17- ona y la sal de metal 3-alcalino de estra-5(10),7-dien-3alfa-ol-17-ona, queson utiles como agentes estrogénicos. También se describe una composicion farmacéutica que los contiene y el uso de losmismos para la fabricacion demedicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83533697A | 1997-04-07 | 1997-04-07 | |
US85057097A | 1997-05-02 | 1997-05-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR012341A1 true AR012341A1 (es) | 2000-10-18 |
Family
ID=27125779
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980101559A AR012341A1 (es) | 1997-04-07 | 1998-04-06 | Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0973790B1 (es) |
JP (1) | JP2001518896A (es) |
KR (1) | KR20010006118A (es) |
CN (1) | CN1259137A (es) |
AR (1) | AR012341A1 (es) |
AT (1) | ATE242263T1 (es) |
AU (1) | AU738486B2 (es) |
BR (1) | BR9809748A (es) |
CA (1) | CA2286457A1 (es) |
DE (1) | DE69815329T2 (es) |
DK (1) | DK0973790T3 (es) |
ES (1) | ES2200334T3 (es) |
NZ (1) | NZ500217A (es) |
PT (1) | PT973790E (es) |
WO (1) | WO1998045315A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG154323A1 (en) * | 2001-03-16 | 2009-08-28 | Wyeth Corp | Estrogen replacement therapy |
WO2009120678A2 (en) * | 2008-03-24 | 2009-10-01 | Signa Chemistry, Llc | Birch reduction of steroid substrates via alkali metal-silica gel materials |
AU2013289344A1 (en) | 2012-07-10 | 2015-02-05 | Bayer Pharma Aktiengesellschaft | 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments |
CA2901632C (en) | 2013-02-21 | 2017-11-07 | Bayer Pharma Aktiengesellschaft | Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (akr1 c3) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1093360B (de) * | 1958-02-17 | 1960-11-24 | Ayerst Mckenna & Harrison | Verfahren zur Herstellung von stabilen antioestrogen wirksamen Verbindungen der Oestranreihe |
US2930805A (en) * | 1959-01-19 | 1960-03-29 | American Home Prod | Novel derivatives of estrane |
US3340278A (en) * | 1965-05-03 | 1967-09-05 | American Home Prod | 5(10), 7-estradiene-3, 17-dione and the process for the production thereof |
SG41955A1 (en) * | 1992-04-07 | 1997-08-15 | Neurim Pharma 1991 | Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia |
-
1998
- 1998-04-02 WO PCT/US1998/006461 patent/WO1998045315A1/en active IP Right Grant
- 1998-04-02 AT AT98915224T patent/ATE242263T1/de not_active IP Right Cessation
- 1998-04-02 AU AU69462/98A patent/AU738486B2/en not_active Ceased
- 1998-04-02 CA CA002286457A patent/CA2286457A1/en not_active Abandoned
- 1998-04-02 ES ES98915224T patent/ES2200334T3/es not_active Expired - Lifetime
- 1998-04-02 BR BR9809748-2A patent/BR9809748A/pt not_active IP Right Cessation
- 1998-04-02 NZ NZ500217A patent/NZ500217A/en unknown
- 1998-04-02 JP JP54288598A patent/JP2001518896A/ja active Pending
- 1998-04-02 CN CN98805884A patent/CN1259137A/zh active Pending
- 1998-04-02 KR KR1019997009196A patent/KR20010006118A/ko not_active Application Discontinuation
- 1998-04-02 PT PT98915224T patent/PT973790E/pt unknown
- 1998-04-02 DK DK98915224T patent/DK0973790T3/da active
- 1998-04-02 EP EP98915224A patent/EP0973790B1/en not_active Expired - Lifetime
- 1998-04-02 DE DE69815329T patent/DE69815329T2/de not_active Expired - Fee Related
- 1998-04-06 AR ARP980101559A patent/AR012341A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
DE69815329T2 (de) | 2004-04-29 |
PT973790E (pt) | 2003-10-31 |
CA2286457A1 (en) | 1998-10-15 |
AU6946298A (en) | 1998-10-30 |
AU738486B2 (en) | 2001-09-20 |
WO1998045315A1 (en) | 1998-10-15 |
CN1259137A (zh) | 2000-07-05 |
KR20010006118A (ko) | 2001-01-26 |
BR9809748A (pt) | 2000-06-20 |
EP0973790A1 (en) | 2000-01-26 |
DK0973790T3 (da) | 2003-09-22 |
DE69815329D1 (de) | 2003-07-10 |
JP2001518896A (ja) | 2001-10-16 |
NZ500217A (en) | 2001-11-30 |
EP0973790B1 (en) | 2003-06-04 |
ATE242263T1 (de) | 2003-06-15 |
ES2200334T3 (es) | 2004-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2174629T3 (es) | 14,15-ciclopropano-esteroides de la serie de los 19-nor-androstanos, procedimiento para su preparacion y formulaciones farmaceuticas que contienen estos compuestos. | |
AR066982A2 (es) | Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos | |
NO962841D0 (no) | Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler | |
ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
PT1033981E (pt) | Formulacoes e metodos para reduzir a toxicidade de agentes antineoplasicos | |
UY26244A1 (es) | Nuevos derivados de quinuclidina y composiciones farmacéuticas que los contienen. | |
BR9810495A (pt) | Composição farmacêutica | |
IT1283102B1 (it) | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele | |
ES2126766T3 (es) | 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo. | |
FI931031A0 (fi) | Mometasonfuroatmonohydrat, foerfarande foer dess framstaellning och farmaceutiska sammansaettningar | |
AR025052A1 (es) | Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos. | |
ATE450254T1 (de) | Schwimmende pharmazeutische zusammensetzung mit einer aktiven phase und einer inaktiven phase | |
AR012341A1 (es) | Compuesto derivados de estradienos, composicion farmaceutica que los contiene y el uso de los mismos para la fabricacion de medicamentos | |
FR2767526B1 (fr) | Composes bi-aromatiques relies par un radical heteroethynylene et compositions pharmaceutiques et cosmetiques les contenant | |
TR200200683T2 (tr) | Oral kontrollü salıverme formülasyonları. | |
NO992999L (no) | Farmasöytisk blanding for oral administrering | |
CO4940457A1 (es) | Composiciones farmaceuticas que comprenden sensibilizadores a insulina para tratamiento de la diabetes | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
PT1001942E (pt) | Poli-hidroxibutilpirazinas sua preparacao e medicamentos que as contem | |
AR015375A1 (es) | Derivados de estrenos, el uso de los mismos para la manufactura de un medicamento, y composicion farmaceutica que los comprende. | |
IT1243751B (it) | Derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
AR031104A1 (es) | Composicion farmaceutica que comprende un carboxialquileter y un agente antihipertensivo, primera composicion para su uso con una segunda composicion que comprenden un agente antihipertensivo y un carboxialquileter respectivamente, equipo que comprende un carboxialquileter y un agente antihipertensi | |
AR012639A1 (es) | Estradieno de anillo b, su uso para la manufactura de un medicamento y composicion farmaceutica que lo contiene. | |
PT1090028E (pt) | 14,15-ciclopropano-androstanos insaturados processo para a sua preparacao e composicoes farmaceuticas que contem estes compostos | |
ES2192870T3 (es) | Derivados de benzofurano, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |